AU2012326201B2 - Method of forming dextran and thrombin sheets - Google Patents

Method of forming dextran and thrombin sheets Download PDF

Info

Publication number
AU2012326201B2
AU2012326201B2 AU2012326201A AU2012326201A AU2012326201B2 AU 2012326201 B2 AU2012326201 B2 AU 2012326201B2 AU 2012326201 A AU2012326201 A AU 2012326201A AU 2012326201 A AU2012326201 A AU 2012326201A AU 2012326201 B2 AU2012326201 B2 AU 2012326201B2
Authority
AU
Australia
Prior art keywords
dextran
thrombin
fibrinogen
hemostatic
support layer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2012326201A
Other languages
English (en)
Other versions
AU2012326201A1 (en
Inventor
Brian Jeffrey JACKSON
Philip A. Messina
Curtis E. Olson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
St Teresa Medical Inc
Original Assignee
St Teresa Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St Teresa Medical Inc filed Critical St Teresa Medical Inc
Publication of AU2012326201A1 publication Critical patent/AU2012326201A1/en
Application granted granted Critical
Publication of AU2012326201B2 publication Critical patent/AU2012326201B2/en
Assigned to ST. TERESA MEDICAL, INC. reassignment ST. TERESA MEDICAL, INC. Amend patent request/document other than specification (104) Assignors: Brian Jeffrey Jackson, CURTIS E. OLSON, Philip A. Messina, ST. TERESA MEDICAL, INC.
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/44Medicaments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/00051Accessories for dressings
    • A61F13/00063Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36Blood coagulation or fibrinolysis factors
    • A61K38/363Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/24Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/26Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/04Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Zoology (AREA)
  • Materials For Medical Uses (AREA)
  • Nonwoven Fabrics (AREA)
AU2012326201A 2011-10-18 2012-10-17 Method of forming dextran and thrombin sheets Active AU2012326201B2 (en)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US201161548261P 2011-10-18 2011-10-18
US201161548258P 2011-10-18 2011-10-18
US201161548260P 2011-10-18 2011-10-18
US61/548,258 2011-10-18
US61/548,261 2011-10-18
US61/548,260 2011-10-18
US201261585303P 2012-01-11 2012-01-11
US61/585,303 2012-01-11
US201261589060P 2012-01-20 2012-01-20
US61/589,060 2012-01-20
US201213785290A 2012-09-19 2012-09-19
US13/622,604 2012-09-19
PCT/US2012/060643 WO2013059341A1 (fr) 2011-10-18 2012-10-17 Procédé de formation de feuilles de dextran et de thrombine

Publications (2)

Publication Number Publication Date
AU2012326201A1 AU2012326201A1 (en) 2014-05-22
AU2012326201B2 true AU2012326201B2 (en) 2016-02-25

Family

ID=48141313

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2012326201A Active AU2012326201B2 (en) 2011-10-18 2012-10-17 Method of forming dextran and thrombin sheets

Country Status (4)

Country Link
EP (1) EP2768541A4 (fr)
AU (1) AU2012326201B2 (fr)
CA (1) CA2854294C (fr)
WO (1) WO2013059341A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3067583A1 (fr) * 2017-06-20 2018-12-27 St. Teresa Medical, Inc. Produits hemostatiques

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110071499A1 (en) * 2009-09-18 2011-03-24 Dorna Hakimimehr Free-standing biodegradable patch
US20110150973A1 (en) * 2008-04-11 2011-06-23 Bowlin Gary L Electrospun dextran fibers and devices formed therefrom

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2350628A1 (fr) * 1998-11-12 2000-05-18 Polymer Biosciences, Inc. Polymere hemostatique permettant une coagulation sanguine rapide et l'hemostase
WO2000033744A1 (fr) 1998-12-08 2000-06-15 University Of Virginia Patent Foundation Dispositif et techniques de fermeture percutanee de sites de perforation vasculaire
US7622628B2 (en) * 2005-05-04 2009-11-24 Innovasa Corporation Hemostatic wire guided bandage and method of use
CN100427652C (zh) 2005-11-11 2008-10-22 东南大学 复合纳米纤维长丝束制备装置及其制备方法
US8277837B2 (en) * 2006-01-11 2012-10-02 Entegrion, Inc. Hemostatic textile
US20090053288A1 (en) 2007-08-20 2009-02-26 Eskridge Jr E Stan Hemostatic woven fabric
US20100100123A1 (en) * 2008-10-17 2010-04-22 Confluent Surgical, Inc. Hemostatic implant
EP2346538B1 (fr) * 2008-11-19 2018-06-27 Actamax Surgical Materials LLC Matériau d étanchéité de tissu fibreux et procédé d utilisation de celui-ci
US20110112572A1 (en) * 2009-11-10 2011-05-12 Tyco Healthcare Group Lp Hemostatic Tapes and Dispensers Therefor

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110150973A1 (en) * 2008-04-11 2011-06-23 Bowlin Gary L Electrospun dextran fibers and devices formed therefrom
US20110071499A1 (en) * 2009-09-18 2011-03-24 Dorna Hakimimehr Free-standing biodegradable patch

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ROTHWELL, S. W. et al: Biologicals (2010) Vol. 38, pp. 619-628 *

Also Published As

Publication number Publication date
EP2768541A4 (fr) 2015-05-06
EP2768541A1 (fr) 2014-08-27
CN104254347A (zh) 2014-12-31
WO2013059341A1 (fr) 2013-04-25
AU2012326201A1 (en) 2014-05-22
CA2854294A1 (fr) 2013-04-25
CA2854294C (fr) 2018-11-20

Similar Documents

Publication Publication Date Title
AU2012326206B2 (en) Method of forming hemostatic products
WO2016112026A1 (fr) Produits hémostatiques
KR20160085267A (ko) 지혈 제품
US20180361012A1 (en) Hemostatic products
AU2012326201B2 (en) Method of forming dextran and thrombin sheets
US10953128B2 (en) Fibrin sealant products
US20200215223A1 (en) Surgical sealant products and method of use
CN104254347B (zh) 形成右旋糖酐和凝血酶片材的方法
WO2016022708A1 (fr) Procédé pour provoquer une hémostase retardée

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE PRIORITY DETAILS TO READ 61/585,303 11 JAN 2012 US; 61/589,060 20 JAN 2012 US; 61/548,261 18 OCT 2011 US; 61/548,258 18 OCT 2011 US; 13/622,604 19 SEP 2012 US AND 61/548,260 18 OCT 2011 US

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE PRIORITY DETAILS TO READ 61/548,260 18 OCT 2011 US; 61/548,258 18 OCT 2011 US; 61/589,060 20 JAN 2012 US; 61/585,303 11 JAN 2012 US; 61/548,261 18 OCT 2011 US AND 13/622,604 19 SEP 2012 US